Clinical Trials Logo

Clinical Trial Summary

To learn about your feelings as a caregiver about the level of discomfort of patients who have hypoactive delirium (loss of contact and response to reality) and who are at the end of life


Clinical Trial Description

Primary Objective: To assess the caregiver's perception of the level of discomfort of patients who have a hypoactive delirium and who are considered actively dying. The caregiver's perception will be based upon the Caregiver Survey of Patient Discomfort. Secondary Objective: To compare the perception of discomfort between the caregiver and bedside nurse. The caregiver's perception will be based upon the Caregiver Survey of Patient Discomfort, and the nurse's perception will be based upon the Healthcare Provider Survey of Patient Discomfort. Exploratory Objective: To assess associations between patient demographics and clinical characteristics as well as caregiver and nurse demographics on corresponding caregiver and nurse survey responses. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05837039
Study type Observational
Source M.D. Anderson Cancer Center
Contact Michael Tang, MD
Phone (832) 468-8895
Email mjtang@mdanderson.org
Status Recruiting
Phase
Start date March 25, 2024
Completion date January 1, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT03215745 - Delirium Prevention in Patients From the Intensive Care Unit (DELA) N/A
Terminated NCT02899156 - Flumazenil for Hypoactive Delirium Secondary to Benzodiazepine Exposure Phase 4
Recruiting NCT03438526 - The Basel BOMP-AID Randomized Trial Phase 4
Recruiting NCT02345902 - Treatment of Hypoactive Delirium and Outcome Measures Phase 3
Completed NCT03954769 - A Pilot Study of "Stanford Proxy Test for Delirium" (S-PTD)
Not yet recruiting NCT05582005 - An Observational Study of Emergence and Hypoactive Delirium After Anesthesia